Another tumor-related marker that is up-regulated in pathological ECs vs. healthy ECs is ABCG2, a multidrug-resistance receptor (MDR) in breast cancer cells [36] that is also expressed by various ECs [37,38]. This evidence concerns the gene ABCG2 and breast cancer.